Releases

23273 items in section

Beyond the Factory Floor: Redefining the China Opportunity

At the 17th Summer Davos, the concept of "China opportunity 2.0" emerged as a focal point for international observers. Moving past the era of low-cost manufacturing and simple market access, this new framework positions China as a global laboratory for high-tech innovation, green energy, and collaborative industrial development.

Via Transportation Investors Face August Deadline in Securities Lawsuit

Investors who purchased common stock in Via Transportation, Inc. following its initial public offering now have until August 10, 2026, to file for lead plaintiff status. A pending class action alleges the company’s IPO documents contained misleading information regarding its growth trajectory and revenue performance.

Rosen Law Firm Targets Manhattan Associates Over Fiduciary Concerns

The Rosen Law Firm is scrutinizing the conduct of Manhattan Associates’ leadership, launching an investigation into potential breaches of fiduciary duty. Shareholders of the NASDAQ-listed company are being urged to review their holdings as the firm evaluates whether directors and officers failed in their legal obligations to the organization.

Halper Sadeh Probes Four Corporate Mergers for Shareholder Dilution

Investors in AvalonBay Communities, Open Lending, Apogee Therapeutics, and Taylor Morrison Home Corporation may face diminished returns following a series of proposed acquisition deals. New York-based law firm Halper Sadeh LLC has launched investigations into these transactions, citing potential breaches of fiduciary duty and violations of federal securities law.

Aureka Launches OpenDDE, an Open-Source Engine for Drug Discovery

Aureka has released OpenDDE, an all-atom biomolecular foundation model designed to serve as a structural reasoning core for therapeutic research. By providing an open-source framework for complex co-folding, the company aims to accelerate the transition of AI-driven biology into a scalable, infrastructure-heavy discipline.

Gravity Game Unite Opens Second Beta Phase for Ragnarok Zero

With servers live across Southeast Asia, Europe, and Oceania, Gravity Game Unite has launched the second open beta test for Ragnarok Zero: Global. Running through July 15, this phase introduces significant mechanical updates and user-generated content features aimed at refining the PC MMORPG experience based on initial player feedback.

Stalemate at State House as Historic Healthcare Strike Looms

Governor Maura Healey convened Massachusetts Nurses Association leaders and Mass General Brigham executives at the State House on Monday, seeking to avert a massive walkout. Despite the high-stakes intervention, MGB representatives offered no movement on contract terms, leaving nearly 4,500 nurses and clinicians poised to strike on Wednesday.

Ademi LLP Probes Crinetics Pharmaceuticals Valuation in Vertex Deal

Shareholders of Crinetics Pharmaceuticals are under scrutiny as Milwaukee-based Ademi LLP investigates whether the company’s $10 billion acquisition by Vertex delivers fair value. The inquiry centers on allegations that internal change-of-control arrangements may prioritize executive interests over those of public investors.

Fred Karlinsky Tapped as Leadership Florida Chair-Elect

Fred E. Karlinsky, who leads the Global Insurance Regulatory & Transactions Practice at Greenberg Traurig, was elected chair-elect of Leadership Florida at the organization’s annual meeting in Orlando. He will spend one year in this position before transitioning to a one-year term as board chair in June 2027.

Europastry to Acquire Highland Baking in North American Expansion

Europastry has reached an agreement to acquire the family-owned Highland Baking Company, a move designed to cement the European firm’s footprint in the U.S. foodservice market. The transaction, steered by global law firm Greenberg Traurig, is set to push Europastry’s annual global revenue beyond the $2.3 billion threshold.

Halper Sadeh Launches Investigations into Four Corporate Mergers

Investor rights firm Halper Sadeh LLC has initiated investigations into Element Solutions Inc, InMed Pharmaceuticals, Huntsman Corporation, and Olin Corporation. The firm is scrutinizing whether these companies breached fiduciary duties or violated federal securities laws during recent merger and acquisition proceedings, potentially disadvantaging ordinary shareholders in favor of insiders.

GeneDx Investors Face Deadline in Securities Class Action

Investors who purchased GeneDx Holdings Corp. common stock between April 16, 2025, and May 4, 2026, face an August 3, 2026, deadline to seek appointment as lead plaintiff. The class action lawsuit, filed in the District of Connecticut, targets the genomics company over alleged misrepresentations regarding its acquisition of Fabric Genomics.

Cutting Fertility Treatment Costs Could Double Birth Rates

A landmark global study presented at the 42nd ESHRE Annual Meeting reveals that halving out-of-pocket expenses for assisted reproductive technology could increase births by 2.67 times. By analyzing data from 22 countries, researchers identified a direct link between household affordability and the successful utilization of fertility treatments.

Cutting Fertility Treatment Costs Could Triple Global Birth Rates

Halving out-of-pocket expenses for assisted reproductive technology could trigger a 2.67-fold increase in successful births, according to a landmark study presented at the 42nd ESHRE Annual Meeting. Researchers analyzed data from 22 regions, identifying a critical affordability threshold that separates nations with high treatment uptake from those where access remains prohibitively expensive.

Zeta Phi Beta Sorority Brings Thousands to Nashville for 2026 Grand Boulé

Thousands of women leaders and community advocates are descending upon Nashville for the Zeta Phi Beta Sorority’s International 2026 Grand Boulé. Running from July 6 through July 11, the gathering centers on the theme "The Extraordinary Power of S.H.E.," focusing on service, professional advocacy, and economic empowerment across the region.

Investors File Securities Fraud Lawsuit Against PicS N.V.

Investors who purchased PicS N.V. stock following the company’s January 30, 2026, initial public offering face significant losses after the firm’s share price plummeted below $9, less than half of its $19 offering price. A securities fraud class action lawsuit now challenges the disclosures provided during the company's market debut.

SIGGRAPH 2026 Sets Stage for Neural Rendering and GPU Innovation

From July 19 to 23, the 53rd annual SIGGRAPH conference in Los Angeles will host industry leaders from NVIDIA, Bolt Graphics, and Tripo AI. These sponsored keynotes aim to map the evolution of digital environments, focusing on the convergence of generative AI, specialized hardware, and physical simulation in interactive media.

American Packaging Corporation Targets Competitive Freezer Aisles

Frozen food brands face a narrow window of opportunity to convert shoppers into buyers once a product hits the shelf. American Packaging Corporation is now scaling its flexible packaging production in Columbus, Wisconsin, to enhance shelf visibility while addressing the mechanical rigors of sub-zero retail environments.

Active Motif Secures Exclusive Global Rights to Arima Genomics Tech

Active Motif will now serve as the exclusive worldwide distributor for Arima Genomics’ Hi-C research products, a move that allows Arima to pivot its resources toward the Aventa clinical diagnostics platform while consolidating 3D genomics tools within Active Motif’s existing multiomics portfolio.

GameChange Energy secures 380 MWp solar tracker contract in Queensland

A 380 MWp solar installation in Queensland has tapped GameChange Energy to provide its Genius Tracker 1P Terrain Following system. The Lower Wonga Solar Farm, a project spearheaded by developer Lightsource bp and EPC contractor INTEC Energy Solutions, marks a major expansion for the infrastructure provider in the Australian market.

AMO Pharma Secures Global Regulatory Green Light for cDM1 Study

Following a six-month consultation with the FDA, MHRA, and Health Canada, AMO Pharma has finalized the design for a registrational clinical trial of AMO-02. The study will target congenital myotonic dystrophy type 1, a severe neuromuscular disorder that currently lacks effective, approved treatment options for affected patients.

Why Modern Sponsorship Is Failing the Mythology Test

Formula 1 and the World Cup demonstrate a singular failure in modern marketing: brands are renting proximity to global spectacles rather than building their own stories. As the 2028 Los Angeles Olympics approach, companies remain fixated on buying visibility, confusing the placement of a logo with the creation of a lasting legend.

Navigating Personal Injury Claims in Berks County

Documentation captured in the immediate aftermath of an accident often dictates the outcome of a legal claim. In a recent HelloNation feature, Reading-based attorney Mark E. Zimmer outlines how medical records, witness statements, and Pennsylvania’s comparative negligence laws function as the primary drivers of liability and compensation in personal injury disputes.

Mastering Monthly Bookkeeping: A Guide for York County Small Businesses

For small business owners in York County, the difference between growth and audit trouble often lies in the monthly ledger. David Riggs, president of Accounting Services of York, LLC, outlines the essential financial habits required to maintain compliance and turn raw transaction data into a strategic roadmap for local operations.

Active Motif Secures Exclusive Global Distribution for Arima Genomics

Carlsbad-based Active Motif has finalized an exclusive worldwide agreement to distribute Arima Genomics' Hi-C products and services. The deal allows Arima to pivot its internal resources toward the development of its Aventa clinical diagnostics platform while leveraging Active Motif’s established commercial infrastructure to reach research institutions globally.

VineBrook Homes Trust Cancels 2026 Annual Meeting After Quorum Failure

A persistent lack of shareholder participation has forced VineBrook Homes Trust to scrap its 2026 Annual Meeting. Despite initial attempts to convene on June 2, the Dallas-based real estate investment trust failed to reach the necessary quorum, leading management to pull all pending proposals from the ballot indefinitely.

Insulet Investors Face August Deadline in Securities Class Action

Investors who held Insulet Corporation securities between February 21, 2025, and May 26, 2026, have until August 31, 2026, to seek lead plaintiff status in a federal class action lawsuit. The litigation centers on allegations that the company misled shareholders regarding the integrity of its manufacturing processes.

AMO Pharma Aligns with Global Regulators on cDM1 Clinical Trial Design

London-based AMO Pharma has secured a unified regulatory pathway from the FDA, MHRA, and Health Canada for its registrational study of AMO-02. The trial will target congenital myotonic dystrophy type 1, a severe neuromuscular disorder, using hospitalization rates as the central metric for evaluating the therapy’s efficacy.

PropAccount Adds Prediction Markets to Prop Firm Platform

Boca Raton-based PropAccount.com is expanding its white-label infrastructure, allowing operators to integrate prediction markets alongside existing Forex, crypto, and equity offerings. The update enables firms to launch event contract challenges within a week, utilizing their current risk management and KYC systems without requiring additional technology stacks.